Nephrol Dial Transplant (1992) 7: 300-305
© 1992 European Renal Association-European Dialysis and Transplant Association
research-article
Endothelin in chronic renal failure
1Departments of Nephrology, Hopital Pitie-Salpetriere Paris, France 2Departments of Biochemistry, Hopital Pitie-Salpetriere Paris, France
Correspondence and offprint requests to: G. Deray, Service de néphrologie, Hôpital de la Pitie, 83 boulevard de l'hôpital, 75013 Paris, France
The aims of the present study were to determine plasma endothelin (ET) in chronically uraemic patients, the renal clearance of endogenous ET in normal dog and man, and the effect of acute volaemic expansion on ET.
The mean plasma ET concentration in haemodialysis patients was 57.5 ± 5 pg/ml before haemodialysis and remained unchanged at 52.5 ± 5 pg/ml after haemodialysis. They were thus significantly elevated both before and after haemodialysis (P<0.01) compared with plasma ET in normal subjects of 20.8 ±0.8 pg/ml. There was no evidence of ET clearance across the cuprophane membrane of the dialyser. Resting plasma ET values in the 15 non-dialysed uraemic patients ranged between 20 and 52.5 pg/ml (mean 38.2 ±2.3 pg/ml), significantly greater than those observed in controls (P<0.01). In CAPD patients, plasma ET was also significantly (P<0.01). elevated (63 ± 10 pg/ml) when compared to controls, and similar to those observed in patients before haemodialysis. In dogs, mean ET did not diminish between the aorta and the renal vein (28.1 ± 1 versus 28.4 ± 2 pg/ml). In man mean ET did not significantly decline between the renal artery and the renal vein (17±3 to 13±0.8 pg/ml). In the seven healthy subjects who received 2000 ml of isotonic saline intravenously ET remained unchanged (24 ±2; 23 ± 1 and 23 ± 2 pg/ml before and 1 and 2h after starting hydration respectively). We have thus shown that plasma ET is elevated in patients with chronic renal failure especially those on dialysis and CAPD. We found no difference between renal arterial and venous ET in dog and in man, suggesting that there is no ET clearance across the kidney in these species. Because ET may act locally on underlying smooth muscle cells rather than as a circulating hormone the pathophysiological importance of this peptide in patients with chronic renal failure remains to be established.
Keywords: chronic renal failure; endothelin; haemodialysis
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  D. H. Endemann and E. L. Schiffrin Endothelial Dysfunction J. Am. Soc. Nephrol., August 1, 2004; 15(8): 1983 - 1992. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Kassab, M. T. Miller, J. Novak, J. Reckelhoff, B. Clower, and J. P. Granger Endothelin-A Receptor Antagonism Attenuates the Hypertension and Renal Injury in Dahl Salt-Sensitive Rats Hypertension, January 1, 1998; 31(1): 397 - 402. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Aubin, G. Le Brun, F. Moldovan, J.-M. Villette, C. Creminon, J. Dumas, L. Homyrda, H. Soliman, M. Azizi, and J. Fiet Sandwich-type enzyme immunoassay for big endothelin-1 in plasma: concentrations in healthy human subjects unaffected by sex or posture Clin. Chem., January 1, 1997; 43(1): 64 - 70. [Abstract] [Full Text] [PDF]
|
|